Immunovia Inc

Immunovia Inc. is a United States company headquartered in Marlborough, Massachusetts. The company is comprised of a small team of 5 employees. Immunovia Inc. develops and provides healthcare diagnostic tests. Their flagship product, IMMray® PanCan-d, is a blood test designed to detect pancreatic cancer in individuals with a heightened risk due to familial or hereditary predisposition. This test focuses on identifying pancreatic cancer at its early stages (stage I and II) when treatment is most effective. The IMMray® PanCan-d test utilizes a proprietary algorithm analyzing 9 biomarkers, primarily proteins, to assess the likelihood of pancreatic cancer presence. This approach offers a proactive tool for at-risk individuals and healthcare professionals to monitor for the disease. For more information about Immunovia Inc. and the IMMray® PanCan-d test, please visit their website at immunoviainc.com.